Wednesday, 25 April 2012

Semiconductor defect detection...

The optimisation and exploitation of compound semiconductors will lead to more efficient lighting, more reliable electric grids, efficient power supplies and ultra-efficient solar cells. The importance of compound semiconductors is demonstrated by the sector’s industrial revenue of around $200 billion per annum.

However, one of the limiting factors in compound semiconductor devices is the presence of defects such as threading dislocations, stacking faults and partial dislocations. The availability of a simple, non-destructive technique to rapidly detect and identify such defects in semiconductors, represents a significant opportunity for the development of laser diodes, high-power transistors and semiconductor based ferromagnets.

Now though, researchers at the University of Strathclyde, have developed a method which allows cost effective, efficient, and unambiguous identification of common defects in semiconductors using the scanning electron microscopy technique of electron channelling contrast imaging. Images are produced from electrons which channel along crystal planes - defects cause deviations from the perfect crystal lattice and give rise to contrast in the image with threading dislocations appearing as black and white spots. The procedure does not require sophisticated sample preparation and so reduces the time required to obtain quantitative and statistically significant information on defects (with an accuracy of approximately 98%).

Vehicle data logger...

Knowing where and what your fleet of vehicles is up to for many businesses is essential to manage costs and efficiencies. Advanced vehicle monitoring systems can help businesses understand how their fleet is being utilised so as to identify operational efficiencies and minimise running costs.

Available from Strathclyde University The Vehicle Data Logger (DLog) is a complete vehicle tracking and performance monitoring system which is capable of monitoring conventional fuelled fleets as well as modern electric vehicles. It has a powerful low cost generic processing platform which can interface with multiple vehicle CAN (Controller Area Network) systems, accelerometers, GPS location systems and other analogue and digital sensors, providing the capability to produce relevant real time information (including real-time vehicle location, drive performance and vehicle diagnostics).

Importantly all detailed drive and diagnostic information is recorded for fleet management and maintenance purposes. This system offers more comprehensive monitoring functionality as well as feedback in a unique fashion to both the driver and the fleet manager.

Now fleet managers can do just that... manage their fleet.

Tuesday, 24 April 2012

DERMOFIT - early identification of skin cancer...

It's a staggering statistic - 500,000 referrals for potential skin cancer are made from primary care to specialist secondary care per year in the UK. Thankfully, however for every confirmed skin cancer case, 10 to 20 turn out benign.

While that is good news for those who are clear it does mean unnecessary referrals waste valuable resource and time, not to mention creating and prolonging  patient anxiety.

DERMOFIT is a diagnostic aid software that helps non-specialists working in primary care to correctly identify skin lesion types, leading to more effective diagnosis and appropriate hospital referrals of skin cancer cases.

Delivered through a mobile, tablet or web-based application, DERMOFIT contains 5000+ high quality images of skin cancers and their mimics, collected under standardised conditions and annotated diagnostically by a team of consultant dermatologists and pathologists. With the addition of training material and assessment features, DERMOFIT may also be suitable to support the training of medical students and other healthcare professionals.

Friday, 20 April 2012

Near hermetic Polymer based Wafer Level MEMS Package Design...

The Proof of Concept Fund from Scottish Enterprise is a powerful way in which to seek support for the development of new ideas and inventions. Supported by the Scottish Enterprise Proof of Concept Programme, a team at Heriot-Watt university in Edinburgh has developed a wafer level process for bonding or encapsulating MEMS, MOEMS, RF-MEMS or other micro-electronic devices.

Using a commercial polymer and advanced electroplating the team have been able to provide a composite structure offering greater barrier properties than polymer only with the added benefit of 3D interconnectivity to reduce device footprint. No only that but the finished pacakges can be bonded at low temperatures.

Ultrafast OPO Laser System for Spectroscopy and Micromachining at 1.5-1.8 Micron Wavelength...

Supported by the Scottish Enterprise Proof of Concept fund and through the UK EPSRC follow on fund Heriot-Watt University has patent pending for a high power laser source in the femtosecond pulse range (sub 500-fs).

This tunable ultrafast OPO laser source is suitable for application within micromachining, waveguide fabrication, and bio-imaging techniques such as multi-photon, Raman, or CARS spectroscopy in the NIR.

The design is such that it offers the benefits of higher pulse energies (up to 1 µJ/ pulse) combined with variable repetition rates, starting from single pulses on demand up to rates approaching 10 MHz. This provides a highly flexible, reliable, and tunable output covering the NIR (1.5 - 1.8 µm) spectral range.

Thursday, 19 April 2012

Efficient synthesising of DNA-binding polyamides...

Strathclyde University has developed a new, highly efficient method of synthesising DNA-binding polyamides.

DNA-binding polyamides are small molecules that can be designed to target virtually any pre-determined DNA sequence and offer a potentially generic approach for the regulation of gene expression. They have the ability to alter disease states and have affinities and specificities that equal or exceed natural eukaryotic transcriptional regulatory proteins, however, a major barrier to the wider use of polyamides has been the ability to prepare diverse collections of polyamides in high yields, quickly and cost effectively. The new developments seeks to address those barriers.

Wednesday, 18 April 2012

Method for selecting inhibitors of Rm1A...

St Andrews University have applied for patent relating to an invention which provides a purified and crystallised form of RmlA and its X-ray structure. In addition, it also provides a method of selecting agents which inhibit the enzyme RmlA, such as, providing a model of the active or regulatory site (s) of RmlA; reviewing the structure of a potential inhibitory agent for at least one of these sites; analysing the potential interaction of said agent in said site (s).

This technology may prove to be of substantial benefit to pharmaceutical and biotechnology companies, to select for anti-microbial compounds for further development. For example, an anti-bacterial or anti-fungal agent which binds to an active or regulatory site of RmlA sufficiently tightly to impede the biosynthesis of rhamnose and thus growth of the micro-organism.

Monday, 16 April 2012

Preventing and treating bacterial infections...

University of Edinburgh researchers have developed a family of peptide mimetics, that are completely resistant to host protease degradation. In both in vitro and in vivo models of infection they show highly efficient entry into eukaryotic cells, without host toxicity, and confer effective antimicrobial killing.

A non‐toxic cell penetrating peptide mimetic with potent antimicrobial activity against clinically important multi‐drug resistant human pathogens has been designed and evaluated by the team. This novel anti-infective has particular utility for the  treatment of intracellular infections and clearance of nonreplicating bacteria impervious to currently available therapeutic regimes.


Wednesday, 11 April 2012

Biopolymer coatings for improved endothelial progenitor cell growth...

Unfortunately vascular intervention surgery is often associated with stent failure or repeat surgery. Now researchers at the University of Edinburgh have identified novel biopolymers to support human endothelial cell growth and the endothelialisation of intra-vascular stents or vascular conduits potentially minimising these problems.

Therapeutic strategies using a patients own stem cells to repair and regenerate damaged tissue have been explored for years. But since circulating endothelial progenitor cells (EPC) were discovered, strategies involving direct implantation or infusion have been limited by poor homing and engraftment in target tissue. This loss of control of cell fate results in transplanted cell death. Introducing a biomaterial scaffold that attracts and supports EPC differentiation to form a mature endothelium should help resolve such issues by promoting cellular engraftment and provide a template to guide new tissue growth.

A team at the University of Edinburgh has now identified a family of biopolymers capable of promoting adhesion and differentiation of human EPC and when used as surface coatings for 3-D scaffolds, were shown to be significantly better than the gold standard GFR-M.

Wednesday, 4 April 2012

Novel : Highly Sensitive Diagnostic for Non-Alcoholic Fatty Liver Disease...

Non-alcoholic fatty liver disease (NAFLD) affects approximately 25% of the Western population and is increasing in prevalence.  There exists an urgent unmet need for the development of non-invasive methods of staging and grading NAFLD to allow early targeted therapy.

Researchers at the University of Dundee have developed a novel, highly sensitive diagnostic tool for Non-Alcoholic Fatty Liver Disease (NAFLD). Capable of distinguishing between the disease states of NAFLD, the system presents a unique opportunity to allow early intervention and monitoring of disease state.

Their test will allow large populations to be easily and cost-effectively screened for the presence of NASH and appropriate therapy implemented.  The panel of markers could also have utility as confirmation of therapeutic efficacy and could be developed as surrogate markers for end points in the evaluation of new therapeutic agents.

Tuesday, 3 April 2012

Ultra fast PCR technology for medical and biosecurity diagnostics

The timely diagnosis and precise identification of infectious agents remains an ever-present challenge for healthcare and biosecurity professionals. Detection of such agents is often possible through a range of assays including culture-based tests and immunoassays. However, these methods may make the time from sampling to result measurable in days due to their inherent lengthy culture and detection methods or may have sensitivity and specificity issues.

A patent now describes a method of heating PCR which directly couples heat into the reactant mixture producing an almost instant temperature increase rise (measured rise time <300ms) along with uniform heating throughout the reactant mixture. Photonase and Health Technologies at Strathclyde University are seeking an industrial collaborator to accelerate integration of the technology into PCR systems.

Fluorinated PET Tracers for Alzheimer’s Disease...

With an aging population the effects of Alzheimer's Disease on the population at large are significant. Damaging not just the individual but putting families under stress and stretching medical resources.

Researchers at the University of Aberdeen have developed novel compounds that can be used to label beta-amyloid protein in the brain. Beta-amyloid protein is one of the charactersitic biomarkers for Alzheimer's disease; the most common form of dementia among the elderly population
Alzheimer’s Disease .